Figma's Brendan Mulligan Reports Stock Transaction
Brendan Mulligan, General Counsel of Figma, Inc., reported a stock transaction involving 9,436 shares, reflecting ongoing management practices in the tech industry.
Alkami Technology's Judson Linville Acquires 420 Shares
Judson C. Linville of Alkami Technology has acquired 420 shares, boosting his ownership to 21,200 shares, reflecting the company's commitment to key personnel.
Chime Financial Co-Founder Ryan A. King Executes Stock Moves
Ryan A. King, co-founder of Chime Financial, reports significant stock transactions, impacting ownership dynamics in the finance services sector.
Chantal Wessels Acquires 25,000 Shares in VenHub Global
Chantal Wessels has increased her stake in VenHub Global, Inc. by acquiring 25,000 shares, reflecting confidence in the company's future.
Ohanessian Shoushana acquires 25,000 shares of VenHub Global
Ohanessian Shoushana increases stake in VenHub Global, acquiring 25,000 shares, signaling confidence in the company's growth potential.
Xos, Inc. Director Edward J. Rapp Acquires Shares
Xos, Inc. director Edward J. Rapp reports share acquisition, reflecting ongoing board member compensation strategies.
Cadrenal Therapeutics CEO Exercises Stock Options
Cadrenal Therapeutics' CEO Pham Quang X exercises stock options, signaling confidence in the company's growth strategy in pharmaceutical preparations.
Cadrenal Therapeutics reports stock option exercise by director
Cadrenal Therapeutics discloses stock option exercise by director John Murphy, emphasizing executive incentives and governance in the pharmaceutical sector.
Innovative Industrial Properties Executes Preferred Stock Purchase
Innovative Industrial Properties Inc. has completed a significant transaction involving its Series B Preferred Stock, signaling a strategic move in the real estate sector.
EVI Industries CEO Nahmad Reports Stock Transaction
Henry M. Nahmad, CEO of EVI Industries, reports a stock transaction involving 8,198 shares, reflecting his commitment to the company.
CFO Lazar Robert Reports Stock Transaction for EVI Industries
Lazar Robert, CFO of EVI Industries, disclosed stock transactions reflecting ownership changes and tax obligations related to restricted stock awards.
Blaize Holdings CRO Patak reports stock transactions
Stephen Paul Patak, Chief Revenue Officer of Blaize Holdings, discloses stock transactions in a recent SEC filing, reflecting ongoing executive activity.
Progressive Corp CEO Susan Griffith Acquires Restricted Stock Units
Susan Griffith, CEO of Progressive Corp, acquires 13.83 restricted stock units, reflecting ongoing executive compensation strategies in the insurance sector.
Joyce Carl G acquires restricted stock units at Progressive Corp
Joyce Carl G, Chief Accounting Officer at Progressive Corp, reports acquisition of restricted stock units, reflecting employee compensation strategies in the insurance sector.
Clawson William L. II acquires restricted stock units at Progressive
Clawson William L. II has acquired 5.351 restricted stock units at Progressive Corp, reflecting ongoing equity management and potential confidence in stock performance.
Progressive Corp President Reports Restricted Stock Units Transaction
Heather E. Day of Progressive Corp disclosed a transaction of 2.555 restricted stock units, emphasizing executive compensation in the insurance sector.
Phelan John W Sells 1,000 Shares of Hills Bancorporation
Phelan John W sells 1,000 shares of Hills Bancorporation, signaling potential shifts in executive confidence within the banking sector.
Moljo Laine Mihalchick Acquires Shares in Avalanche Treasury
Moljo Laine Mihalchick reports acquisition of shares in Avalanche Treasury Corp, signaling strategic developments in the finance services sector.
Lawrence Paul James Reports Share Transaction for Tax Obligation
Lawrence Paul James, CFO of Commercial Metals Co, reports a share transaction to meet tax obligations, reflecting ongoing financial strategies in the steel industry.
BioNTech CEO Sahin Ugur Sells 24,000 Shares in Transaction
Sahin Ugur, CEO of BioNTech SE, sells 24,000 shares at $95.86 each, reflecting strategic decisions under a trading plan.